CAS: 1392116-14-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | JD 5037 REF: IN-DA01EONNCAS: 1392116-14-1 | 98% | To inquire | Mon 31 Mar 25 |
 | JD-5037 REF: TM-T4453CAS: 1392116-14-1 | 98.14% - 98.87% | 44.00 €~550.00 € | Mon 07 Apr 25 |
 | JD 5037 REF: 3D-FJ166461CAS: 1392116-14-1 | Min. 95% | To inquire | Mon 12 May 25 |
JD 5037
CAS:1392116-14-1
Formula:
C27H27Cl2N5O3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
572.506
Ref: IN-DA01EONN
| 10mg | 196.00 € | ||
| 25mg | 517.00 € | ||
| 50mg | 621.00 € |
Estimated delivery in United States, on Monday 31 Mar 2025
JD-5037
CAS:1392116-14-1
JD-5037 is a novel, peripherally restricted CB1R antagonist with an IC50 of 1.5 nM.
Formula:
C27H27Cl2N5O3S
Purity:
98.14% - 98.87%
Color and Shape:
Solid
Molecular weight:
572.51
Ref: TM-T4453
| 1mg | 44.00 € | ||
| 2mg | 58.00 € | ||
| 5mg | 95.00 € | ||
| 10mg | 140.00 € | ||
| 25mg | 246.00 € | ||
| 50mg | 369.00 € | ||
| 100mg | 550.00 € | ||
| 1mL*10mM (DMSO) | 106.00 € |
Estimated delivery in United States, on Monday 7 Apr 2025
JD 5037
CAS:1392116-14-1
JD 5037 is a monoclonal antibody that inhibits the binding of endocannabinoids to their receptors. …
Formula:
C27H27C12N5O3S
Purity:
Min. 95%
Molecular weight:
645.73 g/mol
Ref: 3D-FJ166461
| 10mg | 331.00 € | ||
| 25mg | 431.00 € | ||
| 50mg | 614.00 € | ||
| 100mg | 1,024.00 € |
Estimated delivery in United States, on Monday 12 May 2025
